Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by University of Chicago
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT01643499
First received: July 16, 2012
Last updated: July 20, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)